Syneos Health colleagues Nick Kenny, PhD, and Stephen Keith, MD, invited ex-FDA Commissioner Peggy Hamburg, MD, for a discussion on the lack of patient diversity in clinical trials. Watch as they discuss the current state of affairs, progress made, and next steps.
Speakers:
- Peggy Hamburg, MD, er FDA Commissioner (2009-2015)
- Nick Kenny, PhD, Chief Scientific Officer, Syneos Health
- Stephen Keith, MD, VP, Medical & Scientific Strategy, Syneos Health
